https://no.prisysbiotech.com/ Ikke - Menneske Primat Forskning Plattform & CRO | PRISYS Bioteknologi https://no.prisysbiotech.com/uploads/39406/logo.png https://no.prisysbiotech.com/safety-evaluation/ Sikkerhetsvurdering https://no.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://no.prisysbiotech.com/nhp-pharmacology/ NHP Farmakologi https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://no.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://no.prisysbiotech.com/biosafety-research/ Forskning om biosikkerhet https://no.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://no.prisysbiotech.com/translation-research/ Oversettelsesforskning https://no.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://no.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://no.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://no.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://no.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://no.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://no.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://no.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://no.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://no.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://no.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://no.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://no.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://no.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://no.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://no.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://no.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://no.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://no.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://no.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://no.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://no.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://no.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://no.prisysbiotech.com/pk-pd-adme/adme.html ADME https://no.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://no.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://no.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://no.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://no.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://no.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://no.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://no.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://no.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://no.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://no.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://no.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://no.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://no.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://no.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://no.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://no.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://no.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://no.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://no.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://no.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://no.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://no.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://no.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://no.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://no.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://no.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://no.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://no.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://no.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://no.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://no.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://no.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://no.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://no.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://no.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://no.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://no.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://no.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://no.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://no.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://no.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://no.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://no.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://no.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://no.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://no.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://no.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://no.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://no.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://no.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://no.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://no.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://no.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://no.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://no.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://no.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://no.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://no.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://no.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://no.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://no.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://no.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://no.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://no.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://no.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://no.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://no.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://no.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://no.prisysbiotech.com/translation-research/clinical-imaging.html Klinisk bildediagnostikk https://no.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinisk bildediagnostikk https://no.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://no.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://no.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://no.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://no.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://no.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://no.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://no.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://no.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://no.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://no.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://no.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://no.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://no.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://no.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Type 2-diabetes mellitus-modell https://no.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Type 2-diabetes mellitus-modell https://no.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://no.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://no.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://no.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://no.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://no.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://no.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://no.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://no.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://no.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://no.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://no.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://no.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://no.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://no.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://no.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://no.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://no.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://no.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://no.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://no.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://no.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://no.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://no.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://no.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://no.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://no.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://no.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://no.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://no.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://no.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://no.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://no.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://no.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://no.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://no.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://no.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://no.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://no.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://no.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://no.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://no.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://no.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://no.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://no.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://no.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://no.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://no.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://no.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://no.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://no.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://no.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://no.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://no.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://no.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://no.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://no.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://no.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://no.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://no.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003085414753280.html Molekylær avbildning i NHP-modeller for translasjonsmedikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://no.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968159064892416.html NHP BehaviorAtlas Webinar|3D NHP atferdssporing for medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://no.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724291972916224.html Oppsummering fra 2025: Hvordan Prisys redefinerer translationell pålitelighet i NHP-forskning https://no.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://no.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17558241164633088.html NHP-basert farmakologi og farmakodynamiske tjenester|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://no.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532776386012160.html Møt Prisys Biotech på kommende EU Roadshow: september 2025 https://no.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://no.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451770172744704.html Prisys Biotech-2025 Mid-Year Review https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://no.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243706410853376.html Møt Prisys i det kommende USA-Roadshow i mars 2025 https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://no.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83992536.html PRISYS Årsrapport 2024: Fremme NHP-modeller og preklinisk forskning https://no.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://no.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77740809.html Prisys Biotech 2024 Q2 Newsletter - Forbedret preklinisk FoU for CNS-terapi med PRISYS kryssreaktive modeller https://no.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://no.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028052110435328.html Hvorfor dyremodeller lykkes eller mislykkes i medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021126283928576.html Kvantitativ PET-målengasjement i NHP for CNS-legemidler https://no.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://no.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014970343400448.html Fra video til data: 3D AI-sporing for NHP-atferd https://no.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://no.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015053526918144.html PET-biodistribusjonsavbildning i ikke-menneskelige primater https://no.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://no.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003077518189568.html PBPK vs. Rommodeller: Hvorfor PBPK er viktig https://no.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://no.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17992981848712192.html Oppsummering av webinar: Fremme translasjonell NHP-forskning gjennom digital atferdsfenotyping https://no.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://no.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990266827596800.html PK biomarkører i preklinisk medikamentutvikling|Eksponering – Respons & PK/PD https://no.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://no.prisysbiotech.com/news/behavior-in-rhesus-17983337832932352.html Spontaneous Self-Injurious Behaviour in Rhesus Macaques: A Translational NHP Model For Neuropsychiatric Drug Development https://no.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://no.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983337695192064.html MIDD- og NHP-effektivitetsmodeller i translasjonsmedikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://no.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973507624559616.html AI-Drevet 3D NHP-atferdsanalyse|Markørløs atferdsfenotyping https://no.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://no.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973507661636608.html Globalt webinar|Kvantifisere kompleks NHP-atferd: Vi introduserer NHP BehaviorAtlas for High-Fidelity 3D Behavioral Fenotyping https://no.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://no.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968159185609728.html AI-Drevet NHP-atferdsanalyse for preklinisk medikamentutvikling|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://no.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973508056884224.html Når skal man introdusere NHP-studier i utvikling av autoimmun medikament https://no.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://no.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973508198343680.html NHP IBD-modeller: Hva Chronic Enterocolitt In Rhesus Macaques Lærer oss om translasjonell tarmbetennelse https://no.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://no.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973507623609344.html MR-Veiledet AAV-levering i NHP-hjernemodeller for CNS-genterapi https://no.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://no.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973510279472128.html Hvorfor positive kontrollmedisiner er viktige i modeller for autoimmune sykdommer|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://no.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973507584058368.html Baseline ADA-screening hos utvaskede-aper for prekliniske biologiske studier https://no.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://no.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968173828088832.html Smertemekanismer: UVB-solbrenthetsmodellen er et viktig translasjonsverktøy https://no.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://no.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968159145600000.html NHP-modeller for maternal høy-fettdiett og fedmeprogrammering hos barn https://no.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://no.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17944330078905344.html Tolkning av klinisk patologi hos hunder og ikke-menneskelige primater i prekliniske studier https://no.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://no.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17944329906545664.html Molecular Imaging Biomarkers: Advancing Translational Research and Drug Development https://no.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://no.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17944330031342592.html Hva er ikke-lineær farmakokinetikk? Mekanismer, kjennetegn og implikasjoner for medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://no.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17944330099876864.html Hvorfor NHP Molecular Imaging er kritisk for translasjonelle PET-studier https://no.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://no.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17944330355647488.html Hva er molekylær bildebehandling og hvorfor er det viktig i legemiddelutvikling? https://no.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://no.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17944330105250816.html NHP Radionuclid Biodistribution Studies: Molecular Imaging For Translational Drug Development https://no.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://no.prisysbiotech.com/news/nhp-heart-failure-model-17944329978504192.html NHP-hjertesviktmodellen støtter translasjonsforskning på genterapi for telomere-restaurering https://no.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://no.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17944329937298432.html Hvordan DSA og CTA Imaging forbedrer kardiovaskulær legemiddelsikkerhetsevaluering https://no.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://no.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17944329822692352.html NHP arteriovenøs shunt-trombosemodell i Cynomolgus-aper for translasjonell antitrombotisk medikamentevaluering https://no.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://no.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888362108429312.html Farmakokinetiske data som en translasjonsbiomarkør https://no.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://no.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888361891324928.html Ikke-menneskelige primatmodeller for lungefibrose: fremme translasjonsnøyaktighet i utvikling av respiratoriske legemidler https://no.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://no.prisysbiotech.com/news/nhp-models-translational-drug-development-17888361806406656.html Hvorfor legemiddelutvikling i økende grad er avhengig av NHP-modeller|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://no.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888362046333952.html PK-data som en farmakodynamisk biomarkør: fremme translasjonell medikamentutvikling gjennom kvantitativ farmakologi https://no.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://no.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17852366360896512.html Ikke-GLP-farmakologistudier for forskriftsmessig innsending: dataintegritet og laboratoriekrav https://no.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://no.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17852366286758912.html Strategisk design av ikke-kliniske farmakokinetiske studier: Fra ADME-profilering til translasjonsbeslutning- https://no.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://no.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17852366142284800.html NHP AV-Shunttrombosemodell for legemiddelsikkerhetsevaluering|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://no.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17852366573151232.html Hva er ikke-lineær farmakokinetikk? Mekanismer og translasjonell PK-evaluering|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://no.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17852366330110976.html Prisys Biotech støtter IND-godkjenning av UX-GIP001 av FDA og CDE|NHP CNS-leveringsplattform https://img01.v15cdn.com/gallery/4x3/157.webp https://no.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17852366193550336.html In vivo immuncellesporing og utvikling av PET-sporstoffer i NHP-modeller|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://no.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17852366099407872.html Dopamine Transporter PET Imaging i NHP-modeller|CNS Imaging|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://no.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17852366069949440.html PET/CT-biodistribusjon i NHP-modeller for CNS-legemiddellevering|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://no.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17852365875405824.html Stor-radiomerking av dyr og in vivo bildebehandlingsplattform for translasjonsutvikling av legemidler https://no.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://no.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17852365789602816.html Hvorfor medikamentutvikling i økende grad er avhengig av NHP-modeller: Den essensielle rollen til primater i translasjonsmedisin|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://no.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17852355372688384.html IPF Drug Development Utfordringer og løsninger|NHP-modeller med CT-bilder og PFT https://no.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://no.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17852365857989632.html AI-markørløst NHP 3D-atferdsanalysesystem for preklinisk forskning https://no.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://no.prisysbiotech.com/news/evaluating-dmpk-properties-17852354969461760.html Evaluering av DMPK-egenskapene til kandidatforbindelser i tidlig legemiddeloppdagelse|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://no.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17852355004916736.html MR-Veiledet CNS-levering i NHP-modeller|Translasjonsplattform for IMRI og CED https://no.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://no.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17852355222692864.html NHP CNS biodistribusjonsstudier|Intratekal RNA-levering|PRISYS Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://no.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17852355380995072.html Translasjonelt PK/PD-rammeverk: Cynomolgus Monkey To Human Dose Prediction|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://no.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724313300722688.html Når smerte blir et minne: Emosjonelle drivere for kronisk smerte og fordelen med NHP-modellen|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://no.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724313254700032.html Multi-Endepoint Pain Assessment: The Future Of Analgesic Drug Development https://no.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://no.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724313354101760.html Hvorfor mislykkes så mange analgetika i prekliniske studier? Svaret ligger i hvordan vi måler smerte https://no.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://no.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724291513246720.html Tidspunktdesign for blodprøvetaking i farmakokinetiske (PK) studier|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://no.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724291057017856.html PK-statistikk: Non-compartmental analyse (NCA) parametere og prekliniske applikasjoner https://no.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://no.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724313361638400.html Hvorfor ikke-menneskelige primatmodeller er kritiske for CNS-oligonukleotidterapi https://no.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://no.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724290546754560.html Urinsyremetabolisme hos mennesker vs aper: translasjonelle implikasjoner for medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://no.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724290753209344.html Ikke-Human Primate MASH-Associated Liver Fibrosis Model|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://no.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724290288477184.html Hvorfor IMRI-Guidet Brain Drug Delivery er avgjørende for presis målretting i NHP-studier https://no.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://no.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674684972950528.html AI-drevet markørløst NHP 3D-atferdsanalysesystem|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://no.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674685033522176.html LPS-Indusert akutt lungebetennelse (ALI) NHP-modell|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://no.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674708694000640.html HDM+SEB-Indusert atopisk dermatitt (AtD)-modell hos Cynomolgus-aper https://no.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://no.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674685300319232.html En- til flere-kompartment PK-modeller forklart|NHP Farmakokinetikk|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://no.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674679025427456.html Hvordan velge en pålitelig preklinisk CRO|Nøkkelkriterier for bioteknologiselskaper|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://no.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674678681216000.html Translational CAR-T-evaluering: In vitro-ekspertise og NHP-studiestøtte – Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://no.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674678914212864.html Hvorfor mislykkes mer enn 90 % av CNS-legemiddelkandidater i kliniske studier? https://no.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://no.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674708701012992.html Parkinsons sykdom prekliniske modeller: en guide til valg av nevrotoksin, genetiske og NHP-modeller|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://no.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674685119767552.html Høy-presisjonslegemiddellevering og kunstig intelligens-drevne NHP-translasjonsplattformer https://no.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://no.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17631734561317888.html Th17-drevne NHP-immunologimodeller|Translasjonsautoimmun forskning hos Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://no.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17631734794003456.html AI-Basert NHP BehaviorAtlas®-system|3D-atferdsanalyseplattform|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://no.prisysbiotech.com/news/rfp-template-for-nhp-studies-17631734691898368.html RFP-mal for NHP-studier|Akselerer preklinisk forskningseffektivitet https://no.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://no.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17631734545277952.html Cold Allodynia Pain Model in Cynomolgus Monkeys|Prisys Biotechnologies https://no.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://no.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17631734578455552.html MR-Veiledet intracerebral legemiddelleveringsplattform|Prisys Biotech CNS Research https://no.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://no.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17631735074530304.html NHP-modeller for luftveissykdom og leveringsplattform for luftveier|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://no.prisysbiotech.com/news/nhp-renal-biopsy-17631734988645376.html NHP nyrebiopsiplattform og modeller for nyresykdom|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://no.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17631734872597504.html PK-studier og målrettet legemiddellevering|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://no.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17631734623216640.html Prisys Biotechnologies' NHP Research And AI-Based Behavioural Analysis Platform https://no.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://no.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17631734520701952.html Nasal-to-brain (N2B) leveringsteknologi for CNS-forskning|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://no.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17631734481363968.html SHR-2004: Et gjennombrudd i VTE-forebygging for pasienter med ovariekreft – en suksesshistorie av Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://no.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540764562613248.html Cynomolgus & Rhesus Monkey-modeller|Prisys Biotech Preclinical CRO https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532775622370304.html Idiopatisk lungefibrose (IPF) NHP -modell|Prisys bioteknisk preklinisk cro https://no.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532775644554240.html Cynomolgus Monkey Biodistribution Studies|Prisys Biotech Preclinical CRO https://no.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://no.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532775741694976.html Prisys Biotech NHP -modeller for hematologi og hjerneslagforskning https://no.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://no.prisysbiotech.com/news/the-importance-of-administration-volume-17532775586194432.html Betydningen av administrasjonsvolum i prekliniske studier|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://no.prisysbiotech.com/news/brain-targeted-drug-delivery-17532775646454784.html Hjerne - målrettet medikamentlevering|Prisys Biotech preklinisk NHP -forskning https://no.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://no.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532775719953408.html ADC Drug Development|Translational PK/PD Framework in Preclinical NHP Studies https://no.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://no.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499919065424896.html NHP smertemodeller for translasjonell medikamentoppdagelse|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://no.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499918913954816.html Serum vs. Plasma: Velge den optimale matrisen for preklinisk bioanalyse https://no.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://no.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499918979671040.html Prekliniske retningslinjer for dosering: IV & PO volum, PH og osmolaritet for nøyaktig PK i NHP og andre arter https://no.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://no.prisysbiotech.com/news/nhp-copd-model-17499919004230656.html Topp KOLS Research Models & Respiratory Platform Excellence av Prisys https://no.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://no.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499918923408384.html NHP akutt blødningsmodell: Et avgjørende verktøy for å akselerere ny hematologi medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://no.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499918880154624.html Pruritus Research: Prisys Biotechs IL-31-induserte NHP-modell for evaluering av anti-thit-terapier https://no.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://no.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451770159408128.html A Guide to Anti-Drug Antibody (ADA) Assessment https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451770219586560.html Respirasjonsterapier: Prisys Biotechs integrerte NHP-plattform for preklinisk forskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451770232415232.html NHP Pain Models: Akselererende smertestillende medikamentutvikling hos Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://no.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451770348069888.html NHP -modellplattformer for å støtte medikamentutvikling i komplekse sykdommer https://no.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://no.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451770406757376.html Viktige hensyn for doseringsvolum, PH og formulering i dyremodeller https://no.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://no.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451770138649600.html Konstruerte eksosomer: revolusjonerende legemiddellevering for CNS-lidelser – Preklinisk innsikt fra Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451770079781888.html Veiledende prinsipper for utvalg av dyrearter i nukleinsyremedisinske toksikologiske studier https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451770162979840.html Prisys Biotechs DSA og IMRI for studier av hematologiske, vaskulære og nyresykdommer https://no.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451769907504128.html Cynomolgus Monkey Pain Models: Driver translasjonsforskning for banebrytende ionkanalterapi https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451770216342528.html Fremme atopisk dermatittforskning: Prisys Biotechs ikke-menneskelige primat (NHP) modell https://no.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://no.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451770074997760.html Prisys Biotechs NHP Atopic Dermatitis Model for antipuritic medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://no.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374220380709888.html Utforming av dyrestudier: Nøkkelbetraktninger for suksess i preklinisk forskning https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374220005942272.html Atopisk dermatitt: Hvordan Cynomolgus apemodeller fremmer presisjonsterapeutika https://no.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://no.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374219956052992.html Astmaforskning: hvorfor ikke-menneskelige primatmodeller er sentrale for utvikling av nye legemidler https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374219922482176.html Forstå antisense oligonukleotid (ASO) farmakokinetikk: nøkkelfaktorer i absorpsjon og distribusjon https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374268461261824.html NHP inhalasjonsstudier for biologiske medisiner: PRISYSs spesialiserte prekliniske CRO-tjenester https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374220004008960.html Avanserte prekliniske inhalasjonsstudier: Tekniske evner og ekspertise hos Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374305958437888.html Forstå farmakokinetikk (PK): Nøkkelparametere og applikasjoner i medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://no.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374220156675072.html Intracerebroventrikulær (ICV) injeksjon: presisjon CNS-levering for preklinisk forskning https://no.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://no.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374219928658944.html Intracerebral (ICM) injeksjon: presisjonsmålretting for CNS-terapi – prekliniske vurderinger https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374220011545600.html Intratekal (IT) injeksjon: en direkte CNS-leveringsvei for avanserte terapier – prekliniske vurderinger https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374219974435840.html Fremme forskning på Parkinsons sykdom med NHP-modellen https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374220232549376.html Prekliniske PK/PD-studier og NHP-modeller for medikamentutvikling|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://no.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299199003616256.html Targeting Interleukin-31 (IL-31): A Novel Frontier in Autoimmune Disease Drug Development – ​​Prisys Biotech NHP-modeller for preklinisk forskning https://no.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://no.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295472696026112.html Ikke-klinisk immunotoksisitetsvurdering: strategi, nøkkelhensyn og metodevalg https://img01.v15cdn.com/gallery/4x3/232.webp https://no.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295472552158208.html Mikrobiell testing og dens innvirkning på ikke-menneskelige primater i prekliniske DMPK-studier https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295472519472128.html Cynomolgus Monkey Endometriosismodell for å fremme terapeutisk forskning https://no.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://no.prisysbiotech.com/news/membranous-nephropathy-model-17295504819495936.html Advancing Membranous Nephropathy (MN) Drug Development: Prisys Biotechs Cynomolgus Monkey Model Platform https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295472812631040.html Farmakokinetikk av inhalerte legemidler: et paradigmeskifte fra systemisk til pulmonal eksponering https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/animal-models-for-womens-health-17295472458851328.html Prisys Biotech: Animal Models For Women's Health Therapeutics https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295472676267008.html Verdens fedme dag|Prisys Biotech NHP Metabolic Models: Powering the Development of Next-Generation Anti-Obesity Therapies https://no.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://no.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295472433619968.html Prisys Biotechs Cynomolgus Monkey Psoriasis Model: Fremme preklinisk farmakodynamikkevaluering https://no.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://no.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295504801096704.html Integrering av farmakokinetikk og farmakodynamikk i medikamentutvikling https://no.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://no.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888361849037824.html Nettseminar på-forespørsel|The Precision Bridge: MRI-veiledet CED og oversettbare NHP-modeller for CNS-legemiddellevering https://no.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://no.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295472715015168.html Hva validerer Proof Of Concept (PoC) i legemiddelutvikling egentlig? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295472364184576.html Dyremodeller|Utfordringer og anvendelser i utvikling av smertemodeller https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295473138148352.html Ikke-klinisk farmakodynamisk forskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243707094901760.html Velge det ideelle ikke-menneskelige primatet for toksikologiske studier: Cynomolgus Makaque, Rhesus Makaque, And Marmoset https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120319.html Målrettet terapi for Parkinsons sykdom: Gjennombrudd i sanntid-MRI-veiledet stamcelletransplantasjon https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295472318669824.html Systemisk lupus erythematosus (SLE) og rollen til dyremodeller i terapeutisk utvikling https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295472462128128.html Ikke-menneskelig primatmodell for revmatoid artritt (RA) https://no.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://no.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295472373392384.html Stereotaktiske instrumenter for dyrehjerner basert på 3D-koordinatsystemer https://no.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://no.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295472599688192.html Dyremodeller for in vivo-testing (1): Etablering og klassifisering https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83992509.html Utforsker potensielle ruter for biologiske stoffer å komme inn i hjernen https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83992521.html Fremme forskning på revmatoid artritt (RA) med ikke-menneskelige primatmodeller https://no.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://no.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83992528.html Utforsker dyremodeller for atopisk dermatitt-medikamenteffekt https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83992526.html Den kritiske rollen til dyremodeller i menneskelig sykdomsforskning https://no.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://no.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83992530.html Parkin-genmangel-apemodell avslører nye mekanismer og terapeutiske mål for Parkinsons sykdom https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83992511.html Ikke-klinisk medikamentutviklingsveiledning: Akutt, subakutt, subkronisk og kronisk generell toksisitetsstudier https://no.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://no.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83992524.html Innovativ Nasal-to-Brain (N2B) legemiddellevering: Omgå blod-hjerne-barrieren https://no.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://no.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83992495.html Muligheter og utfordringer for minigriser som en ikke-klinisk stor dyreart https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83100163.html Legemiddelleveringsstrategier for hjernesykdommer https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83048517.html Sann-intraoperativ MR-navigasjon: Støtter FDA-godkjenning av den første genterapien for AADC-mangel https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83049549.html Okulære toksisitetsstudier av øyedråper: legemiddeleksponering og sikkerhetsvurdering https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82773339.html Prisys Biotech etablerer Cynomolgus Monkey Psoriasis-modell for å akselerere legemiddelutvikling https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82773321.html Omfattende ikke-humane primatmodeller for nyresykdomsforskning av Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82773318.html Omfattende preklinisk sikkerhetsevaluering av antistoff-medikamentkonjugater (ADC) i ikke-humane primater https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82773316.html Farmakokinetisk evaluering av antistoff-medikamentkonjugater (ADC) i ikke-humane primater https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82773315.html Farmakodynamikkvurdering av ADC https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82773317.html Forstå DMPK av ADC-medisiner https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82773320.html Fremgang i utviklingen av nukleinsyremedisiner og Prisys Biotechs forskningskapasitet https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82322816.html Fremskritt innen mRNA-pulmonal leveringssystemer og Prisys biotechs innovative tjenester https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82773329.html Hvorfor ble Nobelprisen i fysiologi eller medisin i 2024 tildelt disse to forskerne som studerte mikroRNA? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82773314.html Farmakokinetiske (PK) vurderinger for sentralnervesystemet (CNS) legemidler https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656472.html Fremskritt innen CNS-forskning: Prisys Biotechs MRI-kompatible hjerneinjeksjonssystem og CED-teknologi https://no.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120316.html Fremskritt av blødning og koagulering Terapeutiske innovasjoner med Cynomolgus Monkey MCAO-modell https://no.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://no.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120317.html DMPK-evaluering av legemidler til sentralnervesystemet (CNS). https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/animal-models-of-human-diseases-81120311.html Dyremodeller av menneskelige sykdommer https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120315.html Innovations in Pain Evaluation: AI-Driven Behavioral Analysis https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/china-experimental-monkey-industry-81120313.html Historie, nåværende status, utfordringer og muligheter for Kinas eksperimentelle apeindustri https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/human-disease-animal-models-81120312.html Menneskelige sykdommer dyremodeller: et avgjørende verktøy for å fremme biomedisinsk forskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120322.html Viktigheten av preklinisk farmakodynamikk i legemiddelutvikling|Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://no.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120309.html Intranasal administrasjon i dyrestudier https://no.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://no.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410536.html Revolusjonerende CNS-medisinutvikling: PRISYS Biotech introduserer IMRI-teknologi https://no.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://no.prisysbiotech.com/news/convection-enhanced-delivery-81120314.html Advancing Precision Medicine: Convection-Enhanced Delivery (CED) Technology av Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120321.html Cynomolgus Monkey Chronic Kidney Disease (CKD) modell av Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://no.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526693.html Ikke-klinisk sikkerhetsvurdering av okulær legemiddellevering ved bruk av Cynomolgus makaker https://no.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://no.prisysbiotech.com/news/compartment-pk-model-81120323.html Forstå rommodeller og ikke-rommodeller i farmakokinetikk https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120310.html Avanserte CNS-leveringsteknikker hos Cynomolgus-aper: Akselererer utviklingen av oligonukleotidmedikamenter https://no.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://no.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526702.html Redusere bruken av ikke-menneskelige primater i ikke-kliniske sikkerhetsvurderinger: Perspektiver fra FDA og industrien https://no.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://no.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79526741.html LCMS preklinisk bioanalyse av LNP-baserte genterapimedisiner https://no.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://no.prisysbiotech.com/news/mrna-based-therapies-past-79526744.html MRNA-baserte terapier: Past https://no.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://no.prisysbiotech.com/news/pk-strategies-of-pdc-79526698.html Farmakokinetiske studiestrategier for peptid-medikamentkonjugater (PDCs) https://no.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://no.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79526712.html Rollen til AAV i genterapi: immunresponser og toksisitet https://no.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://no.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79526700.html Optimaliserte ikke-kliniske immunogenisitetsevalueringsstrategier https://no.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://no.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79526730.html Farmakodynamisk (PD) evaluering av genterapi https://no.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://no.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526727.html Farmakokinetikk og bioanalyse av oligonukleotidlegemidler-(1) https://no.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://no.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526736.html Farmakokinetikk og bioanalyse av oligonukleotidlegemidler: Absorpsjon og plasmafarmakokinetikk (PK) egenskaper https://no.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://no.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79526726.html Faktorer å vurdere for immunogenisiteten til oligonukleotidlegemidler https://no.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://no.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79526743.html MRNA: Et kraftig og allsidig verktøy for å bekjempe sykdommer-Prisys-Bioteknologi https://no.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://no.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79526723.html Kinesiske forskere tilbyr nye strategier for å reversere kjernesymptomer på Parkinsons sykdom https://no.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://no.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526719.html Prisys Bioteknologi: Nye lipid-nanopartikler for MRNA-levering i primater https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526717.html Viktigheten av translasjonsmedisinsk forskning fra grunnforskning til kliniske studier https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79526729.html Hovedfaktorene som vurderes i WOE-analyse https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526711.html Hvordan levere biologi til hjernen? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526704.html Hvordan legemidler beveger seg og endrer seg i kroppen vår: En kort introduksjon til farmakokinetikk https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79526707.html Hvordan utvikle nye medikamenter raskere og sikrere: En guide til prekliniske DMPK-studier https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79526734.html Retningslinjer for gruppehus for laboratorieaper https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79526706.html Den viktige rollen til eksperimentelle aper i å fremme vitenskapelig forskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79526733.html Forstå Macaca Fascicularis (Cynomolgus Monkey): Nøkkelegenskaper og bidrag til biomedisinsk forskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526722.html Revolusjonerende behandling av metabolske sykdommer: fremskritt og utfordringer i utvikling av peptidmedikamenter https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526709.html Hvordan evaluere sikkerheten til hudprodukter før kliniske forsøk? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79526732.html Den betydelige rollen til eksperimentelle aper i innovativ medikamentutvikling: en innsidekikk på virksomheten https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79526713.html Levertoksisitet som en nøkkelbekymring for SiRNA-medisiner: En omfattende analysemålspesifisitet: The Double-Egeded Sword Of SiRNA https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526703.html Advancing SiRNA Therapeutics: Overcoming Challenges in Drug Development https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526714.html Bruksutsikter for genmedisiner basert på lipidnanopartikler https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79526721.html Nøkkelpunkter i utforming av strategier for ikke-kliniske studier på unge dyr https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526710.html Innsikt i de sensoriske og atferdsmessige egenskapene til ikke-menneskelige primater (NHPs) https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79526716.html Evaluering av ikke-klinisk studie, spørsmål og svar https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/significance-principles-and-requirements-of-79526742.html Betydning, prinsipper og krav til sikkerhetsfarmakologiforskning https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79526724.html Hvordan evaluere preklinisk farmakologisk effekt? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79526695.html Refleksjoner over ikke-kliniske farmakologiske studier og evaluering av terapeutiske legemidler for ikke-alkoholisk Steatohepatitt (NASH) https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526708.html Fremme CNS- og CGT-forskning: Prisys Biotechnologies https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79526728.html Retningslinjer for innsamling av ikke-human primater cerebrospinalvæske https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526720.html Betraktninger for å tolke data om klinisk patologi hos ikke-menneskelige primater (NHP) og hjørnetenner https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526690.html ​​​Integrere CNS-sikkerhetsevaluering i generelle toksikologiske studier https://no.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://no.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526697.html Hvordan utføre preklinisk farmakologi/toksikologisk evaluering av ADCer? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526694.html ADME-innsikt for oligonukleotidmedisiner (1) - Absorpsjon, distribusjon https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526701.html ADME-innsikt for oligonukleotidmedisiner (2) - Metabolisme og utskillelse https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526705.html Prekliniske dyrestudier (1) - Dyrearter https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526718.html Utfordringer og strategier for tolkning av klinisk patologi i prekliniske studier av hjørnetenner og ikke-menneskelige primater https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79526738.html Prekliniske dyrestudier (2) - Administrasjonsveier og -volumer https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/mrna-based-therapies-present-79526745.html MRNA-baserte terapier: Nåværende https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79526739.html MRNA-baserte terapier: fremtid og utfordringer https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79526737.html Kort introduksjon om biologisk analyse av genterapi https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410537.html Cynomolgus Monkey i Ophthalmic Drug Research https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410538.html Translasjons- og kryss-reaktive studier med Prisys' NHP-modeller for immunologi og inflammasjon https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185585.html Ikke-naive NHPs in Preclinical Trials: A Cost-Effective Solution By Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/nhp-asthma-model-79185581.html NHP Astmamodell: Styrke studier av prekliniske medikamenteffektivitet med Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185583.html Fremme immunologi og inflammasjonsforskning med Cynomolgus Macaques-modeller - Prisys Biotechnologies https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185580.html Direkte levering av oligonukleotidmedisiner til CNS og vanlige histopatologiske endringer https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185579.html Intra-Cerebrovascular Stroke (ICH) modell av Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75174489.html Ikke-klinisk farmakodynamisk forskning: et essensielt aspekt i utviklingen av SiRNA-medisiner https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77740790.html MR-Guidet stordyrs sentralnervesystem presisjonslokalisering og leveringssystem legger seg i Prisys Biotech https://no.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://no.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77070738.html Innovative løsninger for å fremme respirasjonsterapi https://no.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://no.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74805238.html Prisys: Advancing Animal Experimentation Through Cynomolgus Makaque Studies https://no.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://no.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76184302.html Prisys oppnår full akkreditering fra AAALAC International: En milepæl i å sikre høye standarder for laboratoriedyrepleie. https://no.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://no.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74687781.html Fremhever nukleinsyreterapi gjennom banebrytende-kant med Prisys Biotech Non-human primatmodeller https://no.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://no.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74200889.html Revolusjonerende CNS-medikamentlevering: Prisys og løftet om intratekal injeksjon https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75174485.html Prisys Biotech 2024 Q1 Newsletter - din pålitelige NonHuman Primate-studiespesialist https://no.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://no.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73618166.html Hvordan ultralyd-veiledet leverbiopsi forbedrer makak-basert forskning https://no.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://no.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73618165.html Retningslinjer for livstidsbruk av ikke-menneskelige primater i biomedisinsk forskning: A Prisys Biotechnology Perspective https://no.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://no.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73025612.html Ikke-menneskelige primater: en kort introduksjon til deres biologiske egenskaper https://no.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://no.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72706038.html Utstillingsanmeldelse|Prisys Biotech skinner på årsmøtet til American Society for Neuroscience (SfN 2023) https://no.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://no.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72323422.html Møt Prisys Biotech på årsmøtet til Society For Neuroscience (SfN 2023) https://no.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://no.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72323424.html Verdens slagdag|Fokus på iskemisk hjerneslag dyremodeller og farmakologi https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72323421.html Prisys Biotech inviterer deg til å delta på SAPA-Kina årsmøte i 2023 https://no.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://no.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72323430.html Verdens Alzheimers dag|Utfordringene og løsningene for AD Drug Development https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72323423.html Prisys Biotechs Cynomolgus Macaque-dyremodell hjelper utviklingen av nye antikoagulerende legemidler https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70981003.html Prisys: Providing High-Quality Animal Experiment Service For The Novel Anti-Koagulasjonsfaktor XI-antistoff BJTJ-1837 https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70981002.html Metode for å etablere en Cynomolgus Monkey-modell for hypertriglyseridemi og dens anvendelse https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70981005.html Farmakologi: Hovedparametre og betydning av farmakokinetikk (PK) https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70981001.html Preklinisk farmakologisk evaluering av onkolytiske virusmedisiner https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/0-70981004.html Hvordan små nukleinsyremedisiner kan transformere behandlingen av CNS-sykdommer: Innsikt fra Prisys Biotechnology, en leverandør av NHP-sykdomsmodeller https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70981006.html Farmakokinetikk, forskningsstrategier og kasusstudier av peptidmedikamenter https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69656637.html Sentrale forskningspunkter for ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://no.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69666347.html Prisys Biotechnology: En leder i NHP CNS Disease Modeling Research Platform https://no.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://no.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309274.html Hvordan gå ned i vekt og kontrollere diabetes med GLP-1-produkter https://no.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://no.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309358.html Hvordan China Monkey hjelper til med å utføre preklinisk forskningseffektivitet? https://no.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://no.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309309.html Hva er effektiviteten til RNAi? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309262.html Prisys Biotech Large Animal Experiment Public Service Platform: lav-kostnad og høy-effektiv løsning for store dyreforsøk https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69083180.html Hvordan AAV-genterapi kan redde synet ditt: De siste gjennombruddene fra ikke-human primatstudier https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69086546.html Prisys Biotech viser frem ikke-menneskelig primatmodellplattform på årsmøtet i Japanese Society of Toxicology https://no.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://no.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69083610.html Den lovende fremtiden for AAV-genterapi hos ikke-menneskelige primater https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69083609.html Hva er lipidnanopartikler for genterapi? https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69085504.html Prisys Biotech inviterer deg til å delta i det 50. årsmøtet til The Japanese Society of Toxicology (JSOT) https://no.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://no.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69083634.html Immunotoksisitetstest, legemiddelsikkerhetsevaluering-PRISYS BIOTECH https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68327546.html En optimal dyremodell av iskemisk hjerneslag etablert ved digital subtraksjonsangiografi-Guidet autologe tromber hos Cynomolgus-aper https://no.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://no.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68121407.html Hvorfor du bør bry deg om ikke-menneskelige primater i forskning og utvikling av nukleinsyremedisin https://no.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://no.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68121406.html Møt Prisys Biotech på 70. JALAS 2023! https://no.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://no.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68121408.html Genterapi skinner med nye godkjenninger for sjeldne sykdommer https://no.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://no.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68121429.html Revolusjonerende legemiddeloppdagelse: Hvordan ikke-menneskelige primater optimaliserer SiRNA-screening for raskere og mer effektive resultater https://no.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://no.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67547639.html Maksimerer SiRNA-farmakologieffektiviteten med ikke-menneskelig primatforskning https://no.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://no.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67547001.html Hvordan ikke-menneskelige primater kan revolusjonere SiRNA-forskning: En omfattende guide https://no.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://no.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67552751.html Feirer verdensdagen for forsøksdyr: hvorfor Prisys er forpliktet til å fremme helsen til ikke-menneskelige primater https://no.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://no.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67549509.html Maksimering av CRISPR/Cas9-forskningseffektivitet med ikke-menneskelige primatmodeller https://no.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://no.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67547640.html Frigjør det terapeutiske potensialet: hvorfor investering i nukleinsyremedisiner er medisinens fremtid https://no.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://no.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67546337.html Låse opp potensialet til ikke-menneskelige primater for å forbedre oppdagelsen av mål for genterapi https://no.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://no.prisysbiotech.com/news/world-parkinsons-disease-day-67549508.html Unite For Parkinsons: Joining Hands To Raise Bevissthet på World Parkinsons Disease Day https://no.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://no.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67544550.html Hvordan bruke ikke-menneskelige primater effektivt i sikkerhetsevaluering av genterapi https://no.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://no.prisysbiotech.com/news/gene-therapy-toxicology-66274641.html Genterapi toksikologisk forskning med Nonhuam Primate https://no.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://no.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66137763.html En omfattende guide for å gjennomføre DMPK-studier for genterapi https://no.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://no.prisysbiotech.com/news/gene-therapy-nhp-model-66137759.html Revolusjonerende medisinsk forskning: Genterapi-gjennombrudd i ikke-menneskelige primatsykdomsmodeller! https://no.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://no.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66137761.html Topp 10 populære spørsmål knyttet til genterapi https://no.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://no.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66137762.html Prisys Biotech: Non-Human Primate Pharmacology For Gene Therapy https://no.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://no.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66137760.html Støtte kvinners helse: En titt på endometriose https://no.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://no.prisysbiotech.com/news/prisys-sot2023-66137758.html PRISYS og Taichu Group samarbeider for SOT-utstillingen i 2023 https://no.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://no.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66137375.html Trenger vi ytterligere studier for smertevurdering? - NHP https://no.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://no.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66137378.html Bli med oss ​​for å feire Verdens dyrelivsdag https://no.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://no.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66137374.html Prisys Shanghai NHP R&D Center lanseres, markerer en milepæl innen farmasøytisk forskning og utvikling i Kina https://no.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://no.prisysbiotech.com/news/meetprisys-sot2023-66137376.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://no.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg